Exact Mass: 324.1968294
Exact Mass Matches: 324.1968294
Found 80 metabolites which its exact mass value is equals to given mass value 324.1968294,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lactapiperanol D
Lactapiperanol B is found in mushrooms. Lactapiperanol B is a constituent of Lactarius piperatus.
Cibaric acid
Cibaric acid is found in mushrooms. Cibaric acid is isolated from damaged fruit bodies of the edible chanterelle mushroom (Cantharellus cibarius). Isolated from damaged fruit bodies of the edible chanterelle mushroom (Cantharellus cibarius). Cibaric acid is found in mushrooms.
11-[3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid
3??-Acetoxy-4??-hydroxy-11(13)-eudesmen-12-oic acid methyl ester
1beta,10beta-epoxy-6beta-(2-semialdehyde acetal hydroxymethylacroyloxy)-8beta-ethoxyeremophil-7(11)-en-12,8alpha-olide
3-Hydroxy-6-isopropyl-3-methyl-9-(5-oxotetrahydrofuran-2-yl)-4,9-decadienoic acid
(2S)-1-[2,6-dimethoxy-4-(prop-2-enyl)phenoxy]-3-ethoxy-3-methylbutan-2-ol|lenisin C
CA6PE2
Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); The position of the carboxylic group was assigned arbitrarily; locations of branching points are undetermined; Digitised from figure: approximate intensities
12-oxo-14,18-dihydroxy-9Z,13E,15Z-octadecatrienoic acid
Lactapiperanol D
Bupivacaine hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents Bupivacaine hydrochloride is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride can be used for the research of chronic pain[1][2][3].
2-(benzylmethylamino)pyridine-5-boronic acid pinacol ester
6-(4-Methylbenzylamino)pyridine-3-boronic acid pinacol ester
trimethyl-[2-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]methoxy]ethyl]silane
sodium 1-(carboxymethyl)-4,5-dihydro-1(or 3)-(2-hydroxyethyl)-2-nonyl-1H-imidazolium hydroxide
C15H29N2NaO4 (324.20249140000004)
2-Benzyloxy-5-methylphenylboronic acid pinacol ester
1,2-Ethanediol - 1,1-methylenebis(4-isocyanatocyclohexane) (1:1)
C17H28N2O4 (324.20489680000003)
2-(4-(benzyloxy)-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Levobupivacaine hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOLE
Antibiotic 1233A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
4-Diphenylacetoxy-1,1-dimethylpiperidinium
C21H26NO2+ (324.19634360000003)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
N-[2-(4-morpholinyl)ethyl]-6,7-dihydro-5H-benzo[2,3]cyclohepta[2,4-d]pyridazin-3-amine
C19H24N4O (324.19500139999997)
Methyl 7-{4-[2-(2-hydroxyethoxy)ethoxy]phenyl}heptanoate
1-(4-Benzylpiperazin-1-yl)-2-(pyridin-2-ylamino)propan-1-one
C19H24N4O (324.19500139999997)
N-[(2R,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
N-[(2S,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
N-[(2S,3S,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
N-[(2R,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
N-[(2S,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
N-[(2R,3S,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
N-[(2S,3R,6R)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
N-[(2R,3R,6S)-6-[2-(cyclopropylmethylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]cyclobutanecarboxamide
C17H28N2O4 (324.20489680000003)
(3R,5R)-7-[(1S,2S,8S,8aR)-8-hydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
2-[(1R,3S,8R,11S,13R,14S)-14-[(Z)-prop-1-enoxy]-2,7,12-trioxatricyclo[9.5.0.03,8]hexadecan-13-yl]acetaldehyde
(9E,13Z,15E)-14,18-dihydroxy-12-oxooctadeca-9,13,15-trienoic acid
2,3-dinor-prostaglandin E2
A prostanoid that is prostaglandin E2 lacking two methylenes in the carboxyalkyl chain.
DG(15:3)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved